Phaos Technology Holdings (Cayman) POAS
NYSE POAS
$0.16 +0.00 (+0.19%)
As of: Aug 21, 2026 · 10:52 AM EDT

Phaos Technology Holdings (Cayman) (POAS) Total Debt (2024 - 2025)

Phaos Technology Holdings (Cayman)'s (POAS) quarterly Total Debt came in at $82654.9 in Q4 2025, down 17.53% on a QoQ basis from $100230.1 in Q2 2025.

Phaos Technology Holdings (Cayman) (POAS) Total Debt (2024 - 2025) Analysis & Trends

Phaos Technology Holdings (Cayman) (POAS) has 2 years of Total Debt data on file, last reported at $82654.9 in Q4 2025.

  • Quarterly Total Debt changed N/A year-over-year to $82654.9 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $82654.9 (changed N/A YoY) and the FY2025 annual result came in at $100321.9, down 76.48% from the prior year.
  • Total Debt eased to $82654.9 in Q4 2025, from $100230.1 in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $426507.1 in Q2 2024 to a low of $82654.9 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Abbott Laboratories 201.72 Bn 196.12 Bn 7.27 Bn 32.61 Bn
2 Stryker 126.49 Bn 123.01 Bn 4.50 Bn 14.94 Bn
3 Medtronic 119.21 Bn 109.99 Bn 6.41 Bn 27.96 Bn
4 Boston Scientific 73.88 Bn 73.35 Bn 3.85 Bn 12.62 Bn
5 Edwards Lifesciences 51.97 Bn 47.71 Bn 1.35 Bn 598.70 Mn
6 Dexcom 34.81 Bn 32.86 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.74 Bn 31.63 Bn 2.18 Bn 10.10 Bn
8 Koninklijke Philips 26.29 Bn 22.97 Bn 4.55 Bn 8.68 Bn
9 Steris 23.24 Bn 22.76 Bn 684.20 Mn 1.89 Bn
10 Phaos Technology Holdings (Cayman) 4.13 Mn 4.09 Mn - 82,654.94

Historic Data

Download Data
DateValue
Oct 31, 2025 82,654.94
Apr 30, 2025 100,230.11
Apr 30, 2024 426,507.07